文献速递瓣膜外科

后叶二尖瓣脱垂所致二尖瓣反流手术的当代结果:AATS成人质量门户分析

Contemporary Results of Operations for Mitral Regurgitation Caused by Posterior Mitral Valve Prolapse: The AATS Adult Quality Gateway.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-10-21

该研究比较了高容量与低容量二尖瓣手术医院中后叶二尖瓣脱垂修复术的结局,并与AATS成人质量门户(AQG)和STS成人心脏手术数据库(STS-ACSD)的预测值对比。高容量医院实际死亡率和大病率低于预测值,而低容量医院修复结局更差。AQG预测与STS-ACSD相似,均证实并深化了对手术量-结局关系的理解。

要点

  • 高容量医院二尖瓣修复实际死亡率0.070%,低于AQG预测0.87%和STS-ACSD预测0.77%。
  • 高容量医院实际重大并发症和死亡率为4.0%,低于AQG预测8.1%和STS-ACSD预测6.5%。
  • 低容量医院修复结局更差,例如手术死亡率为3/145(2.1%)。

核心结论

  • AQG预测与STS-ACSD相似,均证实并深化了对后叶二尖瓣脱垂手术量-结局关系的理解。

研究设计与样本

  • AQG训练集包含55,246例成人患者,其中5家医院实施了1,517例二尖瓣手术(修复1,471例,97%;置换46例,3.0%)。
  • 另有14家医院实施了159例二尖瓣手术(修复145例,91%;置换14例,8.8%)。

主要发现

  • 高容量医院中,AQG预测死亡率为0.87%,STS-ACSD预测为0.77%,实际死亡1例(0.070%)。
  • 高容量医院中,AQG预测重大并发症和死亡率为8.1%,STS-ACSD预测为6.5%,实际为4.0%。
  • 接受瓣膜置换的患者更可能年龄更大、症状更重,并伴有更多三尖瓣反流和二尖瓣环钙化。
  • 低容量医院中所有修复结局更差,例如手术死亡率为3/145(2.1%)。

关键数值与推荐

  • 二尖瓣修复技术包括叶片切除(80%)、人工腱索(20%)和瓣环成形(99%)。
  • 手术入路为胸骨切开或部分胸骨切开945例(64%),前外侧开胸或机器人525例(36%)。

临床怎么用

  • AQG仅需有限数据录入并采用虚拟孪生等新统计方法,可提供与STS-ACSD相似的预测,用于质量评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In patients undergoing surgical repair of posterior mitral valve prolapse, we compared outcomes in high- and low-volume mitral surgery hospitals to those predicted by the AATS Adult Quality Gateway (AQG) and the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD). METHODS: Five hospitals performed 1,517 mitral valve operations, 1,471 repairs (97%) and 46 replacements (3.0%), in the AQG training set of 55,246 adult patients. Mitral repair techniques included leaflet resection (80%), creating artificial chordae (20%), and anuloplasty (99%); surgical approach was sternotomy or partial sternotomy in 945 (64%) and anterior thoracotomy or robotic in 525 (36%). The remaining 14 hospitals performed 159 mitral valve operations, 145 repairs (91%) and 14 (8.8%) replacements. RESULTS: In high-volume hospitals, predicted mortality by AQG was 0.87% and by STS-ACSD 0.77%; however, observed mortality was 1 patient (0.070%). For major morbidity and mortality, AQG predicted 8.1% and STS-ACSD 6.5%, but observed was 4.0%. Patients undergoing valve replacement were more likely to be older and more symptomatic and had more tricuspid regurgitation and mitral anular calcification. All repair outcomes were worse (e.g., operative mortality was 3/145 [2.1%]) in low-volume hospitals. CONCLUSIONS: Requiring limited data entry and employing novel statistical methodology (e.g. virtual twins), AQG provided predictions similar to those of STS-ACSD, both confirming and augmenting understanding of the volume-outcome relationship in surgical management of posterior mitral valve prolapse.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gillinov M, Svensson LG, Blackstone EH, et al. Contemporary Results of Operations for Mitral Regurgitation Caused by Posterior Mitral Valve Prolapse: The AATS Adult Quality Gateway. J Thorac Cardiovasc Surg. 2026. PMID: 42906739. doi:10.1016/j.jtcvs.2026.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。